← Back to Search

Behavioral Intervention

Exposure Therapy for Eating Disorders

N/A

Waitlist Available

Led By Jamal Essayli

Research Sponsored by Milton S. Hershey Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be English speakers, ages 18 - 65 years, of all genders, with AN-spectrum disorders, defined as a diagnosis of AN, atypical AN, or AN in partial remission.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up discharge_session 20 (week 20)

Awards & highlights

Study Summary

This trial will evaluate an innovative treatment combining real-life and mental exposure to help people with anorexia reduce anxiety around eating and weight gain.

Who is the study for?

This trial is for adults with eating disorders, specifically those who have been diagnosed with anorexia or anorexia nervosa. Participants should be open to trying a new therapy that involves facing their fears about eating and weight gain.Check my eligibility

What is being tested?

The study is testing Exposure Therapy for individuals with anorexia spectrum disorders. It aims to reduce anxiety related to eating and gaining weight by combining real-life experiences (like eating feared foods) with mental exercises.See study design

What are the potential side effects?

Potential side effects are not explicitly listed, but exposure therapy can sometimes cause increased anxiety temporarily as patients confront their fears directly during the treatment process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65, speak English, and have been diagnosed with an anorexia nervosa spectrum disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ discharge_session 20 (week 20)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~discharge_session 20 (week 20)

This trial's timeline: 3 weeks for screening, Varies for treatment, and discharge_session 20 (week 20) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Body Shape Questionnaire (BSQ)

Clinical Impairment Assessment (CIA)

Demographic Form

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Exposure TherapyExperimental Treatment1 Intervention

Exp-AN will effectively target anxiety related to eating and weight gain via inhibitory learning, and improve treatment outcomes.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exposure Therapy

2016

N/A

~170

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor

495 Previous Clinical Trials

2,798,854 Total Patients Enrolled

2 Trials studying Eating Disorders

99 Patients Enrolled for Eating Disorders

Jamal EssayliPrincipal InvestigatorPenn State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What type of individuals would be ideal participants for this research?

"To be considered for admission to this trial, prospects must have anorexia nervosa and fall within the age range of 18-65. The research team expects to recruit approximately 20 participants in total."

Answered by AI

Are there any opportunities for those interested to partake in this trial?

"This trial has concluded the recruitment process as displayed on clinicaltrials.gov; it was initially posted to the website in December 14th 2023 and last updated a day later. Though this research is no longer looking for participants, there are still 178 other ongoing trials that require patient enrolment."

Answered by AI